NVO240719C152500
- 0.01
- -0.08-88.89%
Novo-Nordisk A/S Newsroom
Obesity Market Will Become More Fragmented
0905 GMT - The obesity market is set to become more complex, with the current duopoly--Novo Nordisk and Eli Lilly--to be weakened, creating several more investment opportunities than currently
Novo Nordisk A/S (NVO) Is Attracting Investor Attention: Here Is What You Should Know
Novo Nordisk's Main Owner Leads $100 Mln Financing of Biotech Firm Asceneuron
By Dominic Chopping Novo Nordisk's owner led a $100 million Series C fundraising in Asceneuron, a biotech company developing therapeutics for neurodegenerative diseases. Novo Holdings, which owns a
Novo-Nordisk (NVO.US) is facing congressional scrutiny in the US due to the discontinuation of its long-acting insulin Levemir in the US market.
Two informed sources said that on Tuesday, Democratic Senate staff will meet with executives from Novo Nordisk to discuss the impact of the company's decision to stop selling a long-acting insulin in the United States.
Novo Holdings Leads $100 Million Series C Financing of Asceneuron to Advance Groundbreaking Therapy for Alzheimer's Disease
COPENHAGEN, Denmark, July 16, 2024 /PRNewswire/ -- Novo Holdings, a leading life science investor, today announces it led a $100 million Series C Financing in Asceneuron, a clinical stage biotech company developing small molecules targeting tau protein aggregation, a driver of neurodegenerative disease.
Bernie Sanders: 'Getting Sick In America Should Not Mean Going Bankrupt, Losing Your Home, Car, Or Life Savings'
Sen. Bernie Sanders (I-Vt.) recently expressed his concerns about the high cost of medical care in the United States, highlighting the financial burden it places on patients.
Top Gap Ups and Downs on Monday: PDD, COIN, JD and More
Gaps can show signals that something important has happened to the fundamental or the psychology of traders that accompanies this market movement.
Novo Nordisk Meeting With Senate Aides Over Levemir: Report
Novo Nordisk (NVO) GLP-1 Drug Regarded Safe for Brain by Oxford
Novo Nordisk Denies Reported Meeting With US Senate Aides Over Insulin Discontinuation
Novo Nordisk (NOVO-B.CO) on Monday denied a report of an upcoming meeting between its senior executives and US Senate aides over the discontinuation of its insulin Levemir in the country.
Market Chatter: Novo Nordisk Reported to Meet Senate Staff Over Decision to Discontinue Levemir Insulin
Novo Nordisk (NVO) executives are reportedly scheduled to meet with Democratic US Senate aides on Tuesday to discuss the repercussions of the company's decision to stop selling one of its long-
Novo Nordisk A/S - Share Repurchase Programme
The New Holy Grail for Weight-Loss Drugs Is Sleep Apnea -- WSJ
Whether millions of people will be able to afford one of the hot new weight-loss drugs could hinge on whether they cure the sleep apnea of people like Damon Sedgwick.
Market Chatter: Novo Nordisk to Meet US Senate Aides Over Levemir Insulin Sales Halt
Novo Nordisk (NOVO-B.CO) is scheduled to meet with Democratic US Senate aides on Tuesday to discuss its decision to stop selling its Levemir long-acting insulin in the US, Reuters reported on July 12, citing two sources familiar with the matter.
Eli Lilly's GLP-1 Impact on ResMed Is Overblown: Barron's
Morgan Stanley Sees $180B Patent Cliff, $380B Deal Capacity Fueling Biopharma M&A
Top Gap Ups and Downs on Friday: WFC, DKS, BK and More
Gaps can show signals that something important has happened to the fundamental or the psychology of traders that accompanies this market movement.
European stock markets rose as US inflation slowed, boosting market sentiment.
European stock markets rose on Friday, achieving their best weekly performance in two months due to slowing US inflation and rising expectations of a September rate cut by the Federal Reserve, which boosted investor sentiment. The Stoxx Europe 600 index rose 0.9% to a high not seen since early June, mirroring gains in the US and boosting risk assets on expectations of a possible rate cut there. Almost all sectors rose, led by consumer stocks, technology firms and retailers. Novo Nordisk, ASML Holding, Siemens and LVMH had the biggest positive impact on the index. Luxury goods companies, which had seen their expected profit declines outpace the broader European market, rebounded on Friday. Uncertainty around the French and British elections.
PFE or NVO: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Large Cap Pharmaceuticals sector have probably already heard of Pfizer (PFE) and Novo Nordisk (NVO).
These Are the Weight Loss Drug Stocks With the Most Upside - SA Sentiment Survey